急性咖啡因摄入对COPD患者耐力表现和心脏自主调节的影响
B M Costa1, A Ferreira Junior1, G Ferreira1
1Department of Physical Education, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
咖啡因摄入改善了慢性阻塞性肺病 (COPD) 患者的耐力运动能力. 虽然咖啡因在运动期间没有影响心率,但咖啡因增加了疲劳和初始心率恢复的时间.
科学领域:
- 运动生理学 运动生理学
- 肺部康复治疗 肺部康复治疗
- 营养科学 营养科学
背景情况:
- 慢性阻塞性肺病 (COPD) 显著影响运动能力和生活质量.
- 了解像咖啡因这样的人体营养助剂可以帮助优化COPD患者的运动表现.
- 心脏自主功能在运动耐受性和恢复中起着至关重要的作用.
研究的目的:
- 评估急性咖啡因 (CAF) 摄入对COPD患者运动表现和心脏自主调节的影响.
- 为了确定CAF是否影响心率 (HR) 和持续负荷运动测试期间疲劳的时间.
- 评估CAF对心率变化 (HRV) 的影响,作为心脏自主调节的指标.
主要方法:
- 一项随机,双盲,安慰剂控制的交叉研究,涉及11名COPD患者.
- 参与者在摄入CAF (5 mg/kg) 或安慰剂 (PLA) 后进行了常量负荷运动测试.
- 在运动和恢复期间,对HR和HRV进行了持续的节拍监测.
主要成果:
- 与安慰剂相比,摄入咖啡因显著增加了疲劳的时间 (p=0.04).
- 在CAF和PLA条件之间没有观察到运动期间HR的显著差异.
- 咖啡因降低了运动后60秒HR恢复的幅度 (p=0.02),但没有改变HRV指数.
结论:
- 急性咖啡因摄入增加了COPD患者的耐力运动表现,通过增加疲劳的时间.
- 在这个人群中,咖啡因似乎不会在运动期间或之后对心脏自主调节产生负面影响.
- 咖啡因可能是一种安全有效的人体工程学辅助剂,用于改善COPD患者的运动能力.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
相关概念视频
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
